156 related articles for article (PubMed ID: 35108035)
1. Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial Cancer.
Choi J; Holowatyj AN; Du M; Chen Z; Wen W; Schultz N; Lipworth L; Guo X
JCO Precis Oncol; 2022 Feb; 6():e2100401. PubMed ID: 35108035
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of Somatic Cancer Gene Variations Among Adults With Appendiceal Cancer by Age at Disease Onset.
Holowatyj AN; Eng C; Wen W; Idrees K; Guo X
JAMA Netw Open; 2020 Dec; 3(12):e2028644. PubMed ID: 33295976
[TBL] [Abstract][Full Text] [Related]
3. Racial/Ethnic and Sex Differences in Somatic Cancer Gene Mutations among Patients with Early-Onset Colorectal Cancer.
Holowatyj AN; Wen W; Gibbs T; Seagle HM; Keller SR; Edwards DRV; Washington MK; Eng C; Perea J; Zheng W; Guo X
Cancer Discov; 2023 Mar; 13(3):570-579. PubMed ID: 36520636
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma.
Li L; Yue P; Song Q; Yen TT; Asaka S; Wang TL; Beavis AL; Fader AN; Jiao Y; Yuan G; Shih IM; Song Y
J Pathol; 2021 Jan; 253(1):119-128. PubMed ID: 33016334
[TBL] [Abstract][Full Text] [Related]
5. Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.
Shi Y; Lei Y; Liu L; Zhang S; Wang W; Zhao J; Zhao S; Dong X; Yao M; Wang K; Zhou Q
Cancer Med; 2021 Apr; 10(7):2216-2231. PubMed ID: 33655698
[TBL] [Abstract][Full Text] [Related]
6. Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
Nair N; Camacho-Vanegas O; Rykunov D; Dashkoff M; Camacho SC; Schumacher CA; Irish JC; Harkins TT; Freeman E; Garcia I; Pereira E; Kendall S; Belfer R; Kalir T; Sebra R; Reva B; Dottino P; Martignetti JA
PLoS Med; 2016 Dec; 13(12):e1002206. PubMed ID: 28027320
[TBL] [Abstract][Full Text] [Related]
7. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
8. Genomic drivers in craniopharyngiomas: Analysis of the AACR project GENIE database.
Lehrich MB; Tong CLC; Hsu PKF; Kuan CE
Childs Nerv Syst; 2024 Feb; ():. PubMed ID: 38421446
[TBL] [Abstract][Full Text] [Related]
9. Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer.
Zheng S; Donnelly ED; Strauss JB
JAMA Netw Open; 2024 Jan; 7(1):e2351906. PubMed ID: 38231514
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma.
Watanabe T; Nanamiya H; Kojima M; Nomura S; Furukawa S; Soeda S; Tanaka D; Isogai T; Imai JI; Watanabe S; Fujimori K
Transl Oncol; 2021 Mar; 14(3):101010. PubMed ID: 33450701
[TBL] [Abstract][Full Text] [Related]
11. Towards less invasive molecular diagnostics for endometrial cancer: massively parallel sequencing of endometrial lavage specimens in women attending for an office hysteroscopy.
Chao A; Wu KY; Lin CY; Lee YS; Huang HJ; Tang YH; Weng CH; Chao AS; Chang TC; Lai CH; Wu RC
J Mol Med (Berl); 2022 Sep; 100(9):1331-1339. PubMed ID: 35953603
[TBL] [Abstract][Full Text] [Related]
12. FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features.
Byron SA; Gartside M; Powell MA; Wellens CL; Gao F; Mutch DG; Goodfellow PJ; Pollock PM
PLoS One; 2012; 7(2):e30801. PubMed ID: 22383975
[TBL] [Abstract][Full Text] [Related]
13. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset.
Hong JH; Cho HW; Ouh YT; Lee JK; Chun Y; Gim JA
J Gynecol Oncol; 2022 May; 33(3):e29. PubMed ID: 35128859
[TBL] [Abstract][Full Text] [Related]
15. Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic Oncology Group study.
Myers AP; Filiaci VL; Zhang Y; Pearl M; Behbakht K; Makker V; Hanjani P; Zweizig S; Burke JJ; Downey G; Leslie KK; Van Hummelen P; Birrer MJ; Fleming GF
Gynecol Oncol; 2016 Apr; 141(1):43-8. PubMed ID: 27016228
[TBL] [Abstract][Full Text] [Related]
16. Impact of age at diagnosis on racial disparities in endometrial cancer patients.
Tarney CM; Tian C; Wang G; Dubil EA; Bateman NW; Chan JK; Elshaikh MA; Cote ML; Schildkraut JM; Shriver CD; Conrads TP; Hamilton CA; Maxwell GL; Darcy KM
Gynecol Oncol; 2018 Apr; 149(1):12-21. PubMed ID: 28800945
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
[TBL] [Abstract][Full Text] [Related]
18. Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer.
Da Cruz Paula A; DeLair DF; Ferrando L; Fix DJ; Soslow RA; Park KJ; Chiang S; Reis-Filho JS; Zehir A; Donoghue MTA; Wu M; Brown DN; Murali R; Friedman CF; Zamarin D; Makker V; Mueller JJ; Leitao MM; Abu-Rustum NR; Aghajanian C; Weigelt B
Gynecol Oncol; 2021 May; 161(2):535-544. PubMed ID: 33622519
[TBL] [Abstract][Full Text] [Related]
19. Endometrial cancer risk and trends among distinct African descent populations.
Medina HN; Penedo FJ; Joachim C; Deloumeaux J; Koru-Sengul T; Macni J; Bhakkan B; Peruvien J; Schlumbrecht MP; Pinheiro PS
Cancer; 2023 Sep; 129(17):2717-2726. PubMed ID: 37357566
[TBL] [Abstract][Full Text] [Related]
20. TP53 mutation and abnormal p53 expression in endometrial cancer: Associations with race and outcomes.
Whelan K; Dillon M; Strickland KC; Pothuri B; Bae-Jump V; Borden LE; Thaker PH; Haight P; Arend RC; Ko E; Jackson AL; Corr BR; Ayoola-Adeola M; Wright JD; Podwika S; Smitherman C; Thomas S; Lightfoot M; Newton M; Washington C; Mullen M; Cosgrove C; Harsono AAH; Powell K; Herzog TJ; Salani R; Alvarez Secord A
Gynecol Oncol; 2023 Nov; 178():44-53. PubMed ID: 37748270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]